Published in Int Immunol on September 01, 2000
Risks for infection in patients with asthma (or other atopic conditions): is asthma more than a chronic airway disease? J Allergy Clin Immunol (2014) 1.52
Asthma status and waning of measles antibody concentrations after measles immunization. Pediatr Infect Dis J (2014) 0.87
What does tympanostomy tube placement in children teach us about the association between atopic conditions and otitis media? Curr Allergy Asthma Rep (2014) 0.75
Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science (1987) 13.03
Suppression of in vivo polyclonal IgE responses by monoclonal antibody to the lymphokine B-cell stimulatory factor 1. Proc Natl Acad Sci U S A (1986) 4.69
T cell-independent antigens type 2. Annu Rev Immunol (1995) 4.62
Anti-immunoglobulin stimulation of B lymphocytes activates src-related protein-tyrosine kinases. Proc Natl Acad Sci U S A (1991) 3.57
Persistent calcium elevation correlates with the induction of surface immunoglobulin-mediated B cell DNA synthesis. J Exp Med (1993) 2.88
Nuclear factor (NF)-kappa B2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J Exp Med (1998) 2.78
Surface immunoglobulin D as a functional receptor for a subclass of B lymphocytes. Immunol Rev (1977) 2.50
Induction of IgG3 secretion by interferon gamma: a model for T cell-independent class switching in response to T cell-independent type 2 antigens. J Exp Med (1992) 2.47
Towards a comprehensive view of immunoglobulin class switching. Immunol Today (1993) 2.44
Absence of the Lyt-2-,L3T4+ lineage of T cells in mice treated neonatally with anti-I-A correlates with absence of intrathymic I-A-bearing antigen-presenting cell function. J Exp Med (1985) 2.27
Increased expression of I-region-associated antigen (Ia) on B cells after cross-linking of surface immunoglobulin. J Immunol (1981) 2.26
Inability of mice with a defect in B-lymphocyte maturation to respond to phosphorycholine on immunogenic carriers. J Exp Med (1977) 2.18
B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms. Immunol Rev (2000) 2.17
T-independent responses in B cell-defective CBA/N mice to Brucella abortus and to trinitrophenyl (TNP) conjugates of Brucella abortus. Eur J Immunol (1978) 2.13
The ontogeny of thymic independent antibody responses in vitro in normal mice and mice with an X-linked B cell defect. J Immunol (1977) 2.03
Polyclonal activation of the murine immune system by an antibody to IgD. II. Generation of polyclonal antibody production and cells with surface IgG. J Immunol (1982) 1.96
Picogram quantities of anti-Ig antibodies coupled to dextran induce B cell proliferation. J Immunol (1988) 1.84
Polyclonal activation of the murine immune system by a goat antibody to mouse IgD. IX. Induction of a polyclonal IgE response. J Immunol (1987) 1.82
T cell independent antigens. Curr Opin Immunol (1995) 1.78
Role of T lymphocytes in the response to TNP-AECM-Ficoll. J Immunol (1980) 1.66
B cell stimulatory factor-1 (interleukin 4) prepares resting murine B cells to secrete IgG1 upon subsequent stimulation with bacterial lipopolysaccharide. J Immunol (1987) 1.66
Interferon-gamma suppresses B cell stimulation factor (BSF-1) induction of class II MHC determinants on B cells. J Immunol (1986) 1.66
CD4+ subset regulation in viral infection. Preferential activation of Th2 cells during progression of retrovirus-induced immunodeficiency in mice. J Immunol (1992) 1.62
Recombinant interferon-gamma inhibits the B cell proliferative response stimulated by soluble but not by Sepharose-bound anti-immunoglobulin antibody. J Immunol (1985) 1.60
Transforming growth factor beta 1 selectivity stimulates immunoglobulin G2b secretion by lipopolysaccharide-activated murine B cells. J Exp Med (1993) 1.56
A model for induction of T cell-independent humoral immunity in response to polysaccharide antigens. J Immunol (1996) 1.56
Activation of soluble polysaccharides with 1-cyano-4-dimethylaminopyridinium tetrafluoroborate for use in protein-polysaccharide conjugate vaccines and immunological reagents. Vaccine (1996) 1.51
Production of BSF-1 during an in vivo, T-dependent immune response. J Immunol (1986) 1.47
Novel in vitro model for high-rate IgA class switching. J Immunol (1995) 1.41
B cells genetically deficient in the c-Rel transactivation domain have selective defects in germline CH transcription and Ig class switching. J Immunol (1997) 1.38
Early development of the T cell repertoire. In vivo treatment of neonatal mice with anti-Ia antibodies interferes with differentiation of I-restricted T cells but not K/D-restricted T cells. J Exp Med (1983) 1.35
Immune response to levan. III. The capacity to produce anti-inulin antibodies and cross-reactive idiotypes appears late in ontogeny. J Immunol (1979) 1.34
Identification of numatrin, the nuclear matrix protein associated with induction of mitogenesis, as the nucleolar protein B23. Implication for the role of the nucleolus in early transduction of mitogenic signals. J Biol Chem (1988) 1.33
Role of the thymus in directing the development of a subset of B lymphocytes. J Exp Med (1982) 1.32
Interferon-gamma inhibits the action of B cell stimulatory factor (BSF)-1 on resting B cells. J Immunol (1986) 1.32
Dextran-conjugated anti-Ig antibodies as a model for T cell-independent type 2 antigen-mediated stimulation of Ig secretion in vitro. I. Lymphokine dependence. J Immunol (1991) 1.29
B cell stimulatory factor 1 (BSF-1) prepares resting B cells to enter S phase in response to anti-IgM and lipopolysaccharide. J Exp Med (1986) 1.27
In vitro and in vivo B lymphocyte-activating properties of monoclonal anti-delta antibodies. I. Determinants of B lymphocyte-activating properties. J Immunol (1986) 1.27
IgE class switching is critically dependent upon the nature of the B cell activator, in addition to the presence of IL-4. J Immunol (1991) 1.27
T cell-derived B cell growth factor(s) can induce stimulation of both resting and activated B cells. J Immunol (1985) 1.26
IL-4 induction of IgE class switching by lipopolysaccharide-activated murine B cells occurs predominantly through sequential switching. J Immunol (1993) 1.24
Cyclic AMP-independent effects of cholera toxin on B cell activation. II. Binding of ganglioside GM1 induces B cell activation. J Immunol (1992) 1.21
Role of a nonimmunoglobulin cell surface determinant in the activation of B lymphocytes by thymus-independent antigens. J Exp Med (1979) 1.19
Surface immunoglobulin crosslinking activates a tyrosine kinase pathway in B cells that is independent of protein kinase C. Proc Natl Acad Sci U S A (1991) 1.19
"Numatrin," a nuclear matrix protein associated with induction of proliferation in B lymphocytes. J Biol Chem (1987) 1.17
Use of the T lymphocyte regulated type 2 antigens for the analysis of responsiveness of Lyb5+ and Lyb5- B lymphocytes to T lymphocyte derived factors. Immunol Rev (1982) 1.16
Polyclonal activation of the murine immune system by an antibody to IgD. I. Increase in cell size and DNA synthesis. J Immunol (1982) 1.16
Regulation of 3' IgH enhancers by a common set of factors, including kappa B-binding proteins. J Immunol (1996) 1.15
T lymphocyte-dependent B lymphocyte proliferative response to antigen. I Genetic restriction of the stimulation of B lymphocyte proliferation. J Exp Med (1981) 1.15
Distinct types of T-cell help for the induction of a humoral immune response to Streptococcus pneumoniae. Trends Immunol (2001) 1.13
B7 requirements for primary and secondary protein- and polysaccharide-specific Ig isotype responses to Streptococcus pneumoniae. J Immunol (2000) 1.11
Size-dependent B lymphocyte subpopulations: relationship of cell volume to surface phenotype, cell cycle, proliferative response, and requirements for antibody production to TNP-Ficoll and TNP-BA. J Immunol (1984) 1.10
In vivo polysaccharide-specific IgG isotype responses to intact Streptococcus pneumoniae are T cell dependent and require CD40- and B7-ligand interactions. J Immunol (1999) 1.10
The importance of theta and Ig hearing cells in the immune response to various antigens. J Immunol (1971) 1.10
Analysis of B cell activation requirements with TNP-conjugated polyacrylamide beads. J Immunol (1979) 1.10
Effects of neonatal anti-delta antibody treatment on the murine immune system. I. Suppression of development of surface IgD+ B cells and expansion of a surface IgM+ IgD- B lymphocyte population. J Immunol (1983) 1.08
Affinity-purified interleukin 2 induces proliferation of large but not small B cells. Proc Natl Acad Sci U S A (1985) 1.06
Heterogeneity of Ia expression on normal B cells, neonatal B cells, and on cells from B cell-defective CBA/N mice. J Immunol (1980) 1.06
Induction of primary and inhibition of secondary antibody response to hapten by hapten conjugates of type III pneumococcal polysaccharide. Cell Immunol (1975) 1.06
Greater sensitivity to inhibition by anti-immunoglobulin of splenic than of bone marrow B-lymphocytes. J Immunol (1973) 1.05
T helper cells grown with hapten-modified cultured Langerhans' cells produce interleukin 4 and stimulate IgE production by B cells. Eur J Immunol (1989) 1.05
Comparative in vitro analysis of proliferation, Ig secretion, and Ig class switching by murine marginal zone and follicular B cells. J Immunol (1993) 1.05
Thymus-derived cell (T cell) activation by heterologous antigens as a replacement of specific immune T cells in the transfer of the secondary response to sheep erythrocytes. J Exp Med (1972) 1.05
Kinetics of B cell memory development during a thymus "independent" immune response. Cell Immunol (1974) 1.04
An in vitro model for T cell-independent induction of humoral immunity. A requirement for NK cells. J Immunol (1994) 1.03
Surface antigens of immunocompetent cells. IV. Effect of anti-b5 allotype on immunologic responses of homozygous b5 rabbit cells in vitro. J Immunol (1972) 1.03
Surface immunoglobulin-mediated B-cell activation in the absence of detectable elevations in intracellular ionized calcium: a model for T-cell-independent B-cell activation. Proc Natl Acad Sci U S A (1989) 1.02
IL-10 selectively regulates murine Ig isotype switching. Int Immunol (1996) 1.01
Enhancement of the mixed lymphocyte reaction by in vivo treatment of stimulator spleen cells with anti-IgD antibody. J Immunol (1983) 0.98
The p65 subunit of NF-kappa B is redundant with p50 during B cell proliferative responses, and is required for germline CH transcription and class switching to IgG3. J Immunol (1999) 0.98
Natural killer cells induce activated murine B cells to secrete Ig. J Immunol (1993) 0.98
Synergistic genetic defect in B-lymphocyte function. I. Defective responses to B-cell stimulants and their genetic basis. J Exp Med (1980) 0.96
Bacterial lipoproteins may substitute for cytokines in the humoral immune response to T cell-independent type II antigens. J Immunol (1995) 0.94
Corticosteroid induction of Ig+Ia- B cells in vitro is mediated via interaction with the glucocorticoid cytoplasmic receptor. J Immunol (1988) 0.93
Identification of a prominent nuclear protein associated with proliferation of normal and malignant B cells. J Immunol (1987) 0.93
IL-10 inhibits T cell-independent but not T cell-dependent responses in vitro. J Immunol (1993) 0.93
Different patterns of inositol polyphosphate production are seen in B lymphocytes after cross-linking of sIg by anti-Ig antibody or by a multivalent anti-Ig antibody dextran conjugate. J Immunol (1989) 0.92
Neonatal suppression with anti-Ia antibody. I. Suppression of murine B lymphocyte development. J Immunol (1982) 0.92
Enhanced protective antibody responses to PspA after intranasal or subcutaneous injections of PspA genetically fused to granulocyte-macrophage colony-stimulating factor or interleukin-2. Infect Immun (1998) 0.92
Polyclonal activation of the murine immune system by an antibody to IgD. VIII. Stimulation of IgD secretion. J Immunol (1987) 0.91
Evidence for DNA binding activity of numatrin (B23), a cell cycle-regulated nuclear matrix protein. Biochim Biophys Acta (1990) 0.91
Biochemical analysis of the immune B cell defect in xid mice. J Immunol (1991) 0.91
Prospects for vaccines during pregnancy and in the newborn period. Clin Perinatol (1997) 0.90
Neisserial porins may provide critical second signals to polysaccharide-activated murine B cells for induction of immunoglobulin secretion. Infect Immun (1997) 0.90
Effects of cholera toxin on human B cells. Cholera toxin induces B cell surface DR expression while it inhibits anti-mu antibody-induced cell proliferation. J Immunol (1990) 0.89